- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/30 - Phosphinic acids [R2=P(:O)OH]Thiophosphinic acids
Patent holdings for IPC class C07F 9/30
Total number of patents in this class: 424
10-year publication summary
|
21
|
19
|
18
|
23
|
16
|
31
|
46
|
40
|
31
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21303 |
30 |
| Clariant Finance (BVI) Limited | 364 |
28 |
| Lier Chemical Co., Ltd. | 44 |
28 |
| UPL Limited | 629 |
22 |
| Merck Patent GmbH | 5725 |
11 |
| Kallyope, Inc. | 67 |
10 |
| Hangzhou DAC Biotech Co., Ltd | 113 |
9 |
| Guangan Lier Chemical Co., Ltd. | 11 |
9 |
| Zhejiang University | 3441 |
6 |
| Zhejiang Wynca Chemical Industry Group Co., Ltd. | 18 |
6 |
| YongNong BioSciences Co., Ltd. | 16 |
6 |
| Ningxia Yongnong Biosciences Co., Ltd. | 12 |
6 |
| AstraZeneca AB | 2818 |
5 |
| Allergan, Inc. | 2169 |
5 |
| CJ Cheiljedang Corporation | 3636 |
5 |
| Clariant International Ltd. | 892 |
5 |
| Metabasis Therapeutics, Inc. | 39 |
5 |
| Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences | 176 |
5 |
| Strategic Enzyme Applications, Inc. | 8 |
5 |
| Arch Biopartners, Inc. | 11 |
5 |
| Other owners | 213 |